Changyi Ou

机构：Sun Yat-sen University, The First Affiliated Hospital, Sun Yat-sen University

发表论文 20 篇 · 总被引 368 次 · h-index 10

代表论文

• International clinimetric evaluation of the MG‐QOL15, resulting in slight revision and subsequent validation of the MG‐QOL15r (2016 · Muscle & Nerve · 被引 158)
• Tacrolimus in the treatment of myasthenia gravis in patients with an inadequate response to glucocorticoid therapy: randomized, double-blind, placebo-controlled study conducted in China (2017 · Therapeutic Advances in Neurological Disorders · 被引 42)
• Quantitative features and clinical significance of two subpopulations of AChR-specific CD4+ T cells in patients with myasthenia gravis (2020 · Clinical Immunology · 被引 40)
• Circulating Th1/17 cells serve as a biomarker of disease severity and a target for early intervention in AChR-MG patients (2020 · Clinical Immunology · 被引 22)
• Leflunomide treatment in corticosteroid-dependent myasthenia gravis: an open-label pilot study (2015 · Journal of Neurology · 被引 20)
• Leflunomide ameliorates experimental autoimmune myasthenia gravis by regulating humoral and cellular immune responses (2021 · International Immunopharmacology · 被引 18)